Cargando…

ING1 and 5-Azacytidine Act Synergistically to Block Breast Cancer Cell Growth

BACKGROUND: Inhibitor of Growth (ING) proteins are epigenetic “readers” that recognize trimethylated lysine 4 of histone H3 (H3K4Me3) and target histone acetyl transferase (HAT) and histone deacetylase (HDAC) complexes to chromatin. METHODS AND PRINCIPAL FINDINGS: Here we asked whether dysregulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakur, Satbir, Feng, Xiaolan, Qiao Shi, Zhong, Ganapathy, Amudha, Kumar Mishra, Manoj, Atadja, Peter, Morris, Don, Riabowol, Karl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423394/ https://www.ncbi.nlm.nih.gov/pubmed/22916295 http://dx.doi.org/10.1371/journal.pone.0043671

Ejemplares similares

Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival
por: Thakur, Satbir, et al.
Publicado: (2015)

Src Regulates the Activity of the ING1 Tumor Suppressor
por: Yu, Lisa, et al.
Publicado: (2013)

Reduced ING1 levels in breast cancer promotes metastasis
por: Thakur, Satbir, et al.
Publicado: (2014)

Tumor cell apoptosis mediated by cytoplasmic ING1 is associated with improved survival in oral squamous cell carcinoma patients
por: Bose, Pinaki, et al.
Publicado: (2014)

The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1 (ING1) by Blocking Polyubiquitination
por: Thalappilly, Subhash, et al.
Publicado: (2011)

Biological Functions of the ING Proteins
por: Dantas, Arthur, et al.
Publicado: (2019)

Aging with ING: a comparative study of different forms of stress induced premature senescence
por: Rajarajacholan, Uma Karthika, et al.
Publicado: (2015)

LincRNA-p21 acts as a mediator of ING1b-induced apoptosis
por: Tran, U M, et al.
Publicado: (2015)

ING1 induces apoptosis through direct effects at the mitochondria
por: Bose, P, et al.
Publicado: (2013)

ING1 induces apoptosis through direct effects at the mitochondria
por: Bose, P, et al.
Publicado: (2013)

ING3 promotes prostate cancer growth by activating the androgen receptor
por: Nabbi, Arash, et al.
Publicado: (2017)

ING1 regulates rRNA levels by altering nucleolar chromatin structure and mTOR localization
por: Rajarajacholan, Uma Karthika, et al.
Publicado: (2017)

Loss of Ing3 Expression Results in Growth Retardation and Embryonic Death
por: Fink, Dieter, et al.
Publicado: (2019)

Interspecies data mining to predict novel ING-protein interactions in human
por: Gordon, Paul MK, et al.
Publicado: (2008)

The ING1a Tumor Suppressor Regulates Endocytosis to Induce Cellular Senescence Via the Rb-E2F Pathway
por: Rajarajacholan, Uma Karthika, et al.
Publicado: (2013)

A minimal ING1b fragment that improves the efficacy of HDAC-based cancer cell killing
por: Boyko, A, et al.
Publicado: (2015)

Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis
por: Boyko, A, et al.
Publicado: (2015)

ING1b-inducible microRNA203 inhibits cell proliferation
por: Chen, J, et al.
Publicado: (2013)

Identification of a Novel Function for the Chromatin Remodeling Protein ING2 in Muscle Differentiation
por: Eapen, Shawn A., et al.
Publicado: (2012)

Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein
por: McClurg, Urszula L, et al.
Publicado: (2018)

Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011)

ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways
por: Wang, F, et al.
Publicado: (2018)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

Integrated RNAi screening identifies the NEDDylation pathway as a synergistic partner of azacytidine in acute myeloid leukemia
por: Klosner, Justine, et al.
Publicado: (2021)

Archibald Inglis
Publicado: (1889)

Mallet-ing
Publicado: (1860)

Inge Borghuis
por: Kiers, Bart
Publicado: (2020)

Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
por: Meyers, Daniel E., et al.
Publicado: (2017)

Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle
por: Wang, Xiaobo, et al.
Publicado: (2023)

Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
por: Raj, Kavita, et al.
Publicado: (2006)

Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells
por: Imanishi, Satoshi, et al.
Publicado: (2017)

Inge J. Lissajoux
Publicado: (2016)

Orbit(ing) the furrow
por: Sreenivasan, Aparna
Publicado: (2004)

SNP'ing for longevity
por: Vijg, Jan
Publicado: (2009)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

Elsie Maud Inglis
por: Russell, Beatrice
Publicado: (1918)

David Wood Inglis
Publicado: (1934)

Professor Inglis of Aberdeen
Publicado: (1875)

Effects of 5-Azacytidine on Growth and Hypocrellin Production of Shiraia bambusicola
por: Ma, Yan Jun, et al.
Publicado: (2018)

Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma
por: Matthews, G M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_72l1rgj3akvjkkmoru0nu3m5mg